CHRS

CHRS Total Assets

$191.18MQuarterly · USD

Period ending:

CHRS FY Total AssetsUSD
CHRS FY Total Assets2012-12-31: $26.53M2013-12-31: $47.45M2014-12-31: $187.22M2015-12-31: $212.38M2016-12-31: $178.49M2017-12-31: $162.61M2018-12-31: $99.47M2019-12-31: $408.93M2020-12-31: $841.65M2021-12-31: $679.33M2022-12-31: $480.85M2023-12-31: $629.60M2024-12-31: $448.53M2025-12-31: $258.34M$841.65M$0.00
2012-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CHRS total assets history

Total value of everything the company owns. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.

Coherus Oncology Inc Total Assets — Annual fiscal periods (USD)
Period endingTotal Assets (USD)
258,343,000
448,533,000
629,604,000
480,847,000
679,334,000
841,649,000
408,927,000
99,467,000
162,611,000
178,485,000
212,384,000
187,221,000
47,447,000
26,533,000

Compare total assets

All CHRS financial metrics · CHRS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.